Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.-论文-万方医学网

作者： Danielle van,Keulen ^[1] ; Marianne G,Pouwer ^[2] ; Valur,Emilsson ^[3] ; Ljubica Perisic,Matic ^[4] ; Elsbet J,Pieterman ^[4] ; Ulf,Hedin ^[5] ; Vilmundur,Gudnason ^[6] ; Lori L,Jennings ^[7] ; Kim,Holmstrøm ^[8] ; Boye Schnack,Nielsen ^[4] ; Gerard,Pasterkamp ^[8] ; Jan H N,Lindeman ^[6] ; Alain J,van Gool ^[9] ; Maarten D,Sollewijn Gelpke ^[10] ; Hans M G,Princen ^[11] ; Dennie,Tempel ^[11]

作者单位： Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. ^[1] Laboratory of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands. ^[2] Quorics B.V., Rotterdam, The Netherlands. ^[3] TNO-Metabolic Health Research, Gaubius Laboratory, Leiden, The Netherlands. ^[4] Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. ^[5] Icelandic Heart Association, Kopavogur, Iceland. ^[6] Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland. ^[7] Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Sweden. ^[8] Faculty of Medicine, University of Iceland, Reykjavik, Iceland. ^[9] Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States. ^[10] Bioneer A/S, Hørsholm, Denmark. ^[11] Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands. ^[12] TNO- Microbiology & Systems Biology, Zeist, The Netherlands. ^[13] Molecular Profiling Consulting, London, United Kingdom. ^[14] SkylineDx B.V., Rotterdam, The Netherlands. ^[15]

主题词动物(Animals);载脂蛋白E类(Apolipoproteins E);动脉粥样硬化(Atherosclerosis);胆固醇酯转运蛋白质类(Cholesterol Ester Transfer Proteins);冠心病(Coronary Disease);内皮细胞(Endothelial Cells);女(雌)性(Female);人类(Humans);炎症(Inflammation);白细胞介素6(Interleukin-6);白血病抑制因子受体α亚单位(Leukemia Inhibitory Factor Receptor alpha Subunit);小鼠, 转基因(Mice, Transgenic);单核细胞(Monocytes);抑瘤素M(Oncostatin M);抑瘤素M受体β亚单位(Oncostatin M Receptor beta Subunit);表型(Phenotype);斑块, 动脉粥样硬化(Plaque, Atherosclerotic);概率(Probability);RNA, 信使(RNA, Messenger);存活率分析(Survival Analysis);血管细胞黏附分子1(Vascular Cell Adhesion Molecule-1)

DOI 10.1371/journal.pone.0221477

PMID 31461490

发布时间 2020-03-03

检索历史清除

Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.

PloS one

相似文献

PloS one

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.

PloS one

相似文献

PloS one

相关期刊

检索历史清除